Zastosowanie antagonistów IL-1 do leczenia dny moczanowej i dny rzekomej

• 收藏
• 分享

专利权人:

Inc.;Regeneron Pharmaceuticals

发明人:

VICARY, CATHERINE,MELLIS, SCOTT

申请号：

PL07839723

公开号：

PL2124997T3

申请日:

2007.10.19

申请国别(地区):

PL

年份:

2013

代理人:

摘要：

Methods of treating, inhibiting, or ameliorating gout, including chronic acute (refractory) gout or pseudogout in a human subject in need thereof, comprising administering to a subject in need a therapeutic amount of an interleukin 1 (IL-1) antagonist, wherein gout or pseudogout are inhibited or ameliorated. Preferably, the IL-1 antagonist is the protein of SEQ ID NO:10 (rilonacept).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/